Profound

Leader

FDA-cleared AI breast cancer detection suite by iCAD (acquired by RadNet 2025). ProFound AI reads 40M+ mammograms globally with 23% improved detection rate.

AI medical imaging
Visit Website
Updated April 2026

Company Overview

ProFound AI is an FDA-cleared AI-powered breast cancer detection suite developed by iCAD, Inc. (acquired by RadNet in July 2025). Built on deep learning, it analyzes 2D and 3D mammograms for cancer detection and density assessment, serving thousands of providers across 50+ countries.

Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Market Leader

Profound is recognized as a market leader in the healthcare sector, demonstrating strong industry presence and customer trust.

Frequently Asked Questions

Compare Profound with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

Start Comparison →
For Profound

Claim This Profile

Are you from Profound? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Profound Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Profound vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →